Global DTP manufacturing capacity and capability. Status report: January 1995

Vaccine

Volumn 14, Issue 4, 1996, Pages 313-320

  Milstien, Julie B ^a   Gellin, Bruce G ^c   Kane, Mark ^a   Di Fabio, José Luis ^b   Homma, Akira ^b  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b PAN AMERICAN HEALTH ORGANIZATION   (United States)

^c NONE

Author keywords

DTP vaccine; quality control; vaccine production

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TOXOID; TETANUS TOXOID;

ARTICLE; DEVELOPING COUNTRY; DRUG FORMULATION; DRUG INDUSTRY; DRUG QUALITY; HUMAN; IMMUNIZATION; PRIORITY JOURNAL; QUALITY CONTROL;

EID: 0029984501     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(95)00181-Y     Document Type: Article

References (3)

1. Homma, A., Di Fabio, J.L., Miranda, D.P. and Oliva, O.F.P. Technical analysis of the state of DTP vaccine production in Latin America and the Caribbean. Bull. PAHO 1994, 283, 256-274
2. Milstien, J.B. and Gellin, B.G. Characteristics of DTP production and control in the Asia Pacific Region. (Paper delivered at CVI Meeting on DTP and DTP-based Combination Vaccines for Asia, Bandung, Indonesia, June 1994)
3. World Health Organization. Technical Report Series 1990, 800, Annex 2